Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
Breast Cancer Research : BCR|November 14, 2012
The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trialHelena Linardou, Konstantine T Kalogeras, Ralf Kronenwett, et al.
Melanoma Research|December 13, 2023
Real-world management practices and characteristics of patients with advanced melanoma initiated on immuno-oncology or targeted therapy in the first-line setting during the period 2015-2018 in Greece. The 'SUMMER' study: a retrospective multicenter chart review projectDimitrios Bafaloukos, Panagiotis Kouzis, Panagiotis Gouveris, et al.
Anticancer Research|August 6, 2005
Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II studyDimosthenis V Skarlos, Haralabos P Kalofonos, George Fountzilas, et al.
Cancer Investigation|September 18, 2008
Gemcitabine combined with gefitinib in patients with inoperable or metastatic pancreatic cancer: a phase II Study of the Hellenic Cooperative Oncology Group with biomarker evaluationGeorge Fountzilas, Mattheos Bobos, Anna Kalogera-Fountzila, et al.
The New England Journal of Medicine|February 17, 2006
Prognostic significance of autoimmunity during treatment of melanoma with interferonHelen Gogas, John Ioannovich, Urania Dafni, et al.
Plos One|August 13, 2013
Ixabepilone administered weekly or every three weeks in HER2-negative metastatic breast cancer patients; a randomized non-comparative phase II trialGeorge Fountzilas, Vassiliki Kotoula, Dimitrios Pectasides, et al.
Journal of Translational Medicine|October 25, 2012
Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumabGeorge Fountzilas, Christos Christodoulou, Mattheos Bobos, et al.
Molecular and Clinical Oncology|February 20, 2016
Lessons from the past: Long-term safety and survival outcomes of a prematurely terminated randomized controlled trial on prophylactic vs. hemoglobin-based administration of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemiaGiannis Mountzios, Gerasimos Aravantinos, Zoi Alexopoulou, et al.
BMC Cancer|February 22, 2014
A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG)George Pentheroudakis, Vassiliki Kotoula, Elena Fountzilas, et al.
Oncology Reports|March 6, 2010
Hyperthermic isolated limb perfusion for recurrent melanomas and soft tissue sarcomas: feasibility and reproducibility in a multi-institutional Hellenic collaborative studyKonstantinos Lasithiotakis, George Economou, Helen Gogas, et al.
Pageof 11